Field Trials Show Practical, Economic Benefits of E. coli Vaccine in Broilers

US - Recent studies on two continents have demonstrated that a modified-live vaccine reduced losses from Escherichia coli in broilers, even when the disease challenge was strong, according to Zoetis in 'Poultry Health Today' recently.
calendar icon 30 May 2014
clock icon 3 minute read
Kalen Cookson Zoetis
Kalen Cookson

The studies were conducted on farms in the US and North Africa.

“There were a variety of conditions, but one thing in common was a higher than normal E. coli challenge,” Kalen Cookson, DVM, MAM, a technical services veterinarian for Zoetis, said at the WVPA conference.

In the US trial, investigators administered the vaccine Poulvac® E. coli to more than four million broilers at hatch. They then compared performance to unvaccinated chicks hatched the previous week that were treated in ovo with the antibiotic gentamycin.

Chicks that received Poulvac E. coli and no gentamycin had a better adjusted feed conversion, lower mortality after week 1 and fewer condemnations compared to controls, yielding a US$0.51 (€0.39) advantage per pound. They also had significantly less disease and needed less antibiotic treatment and for a shorter duration of time, he said.

One of the field trials in North Africa involved two broiler houses with 8,000 birds each on a farm with high E. coli mortality. Investigators treated all birds with an antibiotic in ovo, and then vaccinated one house with Poulvac E. coli at three days of age. The other house was not vaccinated but was treated with enrofloxacin for the first three days of life.

At 40 days of age, vaccinated birds had lower total mortality, better bodyweight and a better feed-conversion ratio (FCR) compared to unvaccinated birds, Dr Cookson told Poultry Health Today.

In another field trial in North Africa involving 15 different farms with a history of E. coli colibacillosis, no preventive in ovo or in-feed antibiotics were administered. Compared to controls, broilers vaccinated with Poulvac E. coli had an overall better average daily gain and FCR and fewer E. coli lesions. When antibiotic treatment was needed, it was necessary for a shorter duration, Dr Cookson said.


Cookson K. et al. 2013. A modified live Escherichia coli vaccine reduces mortality and colibacillosis in broiler field trails. 2013 World Veterinary Poultry Association Conference, Nantes, France. FDAH Study #B510-09-RFt.R (US trial report) and FDAH Study #3113C- 39-10-347 (Moroccan trial report).

Further Reading

Find out more information on colibacillosis in chickens by clicking here.

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.